Stratification of non-small cell lung cancer patients for therapy with epidermal growth factor receptor inhibitors: the EGFR fluorescence in situ hybridization assay

Lignende værker

• EGFR fluorescence in situ hybridisation assay: guidelines for application to non-small-cell lung cancer
  af: Varella-Garcia, M, et al.
  Udgivet: (2009)
• Increased EGFR Gene Copy Number Detected by Fluorescent In Situ Hybridization Predicts Outcome in Non–Small-Cell Lung Cancer Patients Treated With Cetuximab and Chemotherapy
  af: Hirsch, Fred R., et al.
  Udgivet: (2008)
• Fluorescence In situ Hybridization Subgroup Analysis of TRIBUTE, a Phase III Trial of Erlotinib Plus Carboplatin and Paclitaxel in Non – Small Cell Lung Cancer
  af: Hirsch, Fred R., et al.
  Udgivet: (2008)
• Chromosomal Abnormalities in Non-Small Cell Lung Carcinomas and in Bronchial Epithelia of High-Risk Smokers Detected by Multi-Target Interphase Fluorescence in Situ Hybridization
  af: Santos Romeo, Maura, et al.
  Udgivet: (2003)
• A combined subtype of small cell lung cancer and adenocarcinoma with epidermal growth factor receptor (EGFR) mutation responds to EGFR tyrosine kinase inhibitors
  af: Zhang, Yong, et al.
  Udgivet: (2018)